McMaster Textbook of Internal Medicine
Interviews
VTE
Differences in risk stratification, prophylaxis, and treatment of thrombosis in patients with cancer...

Differences in risk stratification, prophylaxis, and treatment of thrombosis in patients with cancer vs patients with nonneoplastic diseases

2015-06-05

Mark Crowther

See also

Management of patients with a history of GI bleeding who require anticoagulant treatment because of a high CHA₂DS₂-VASc score How should we manage patients with a history of gastrointestinal bleeding who require anticoagulant treatment because of a high CHA₂DS₂-VASc score? Should we prefer novel oral anticoagulants in such patients?

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.